| Browsing Drugs by Class |  |
All drug classes > antineoplastics > tyrosine kinase inhibitors
Tyrosine kinase inhibitors
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
Filter drugs by condition:
Drug Name  ( View by: Brand | Generic )
|
Reviews | Avg. Ratings |
|---|---|---|
| imatinib systemic (Pro, More...) |
2 Review(s) | 8.7
Rate It! |
| nilotinib systemic (Pro, More...) |
1 Review(s) | 6.0
Rate It! |
| dasatinib systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first |
| erlotinib systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first |
| gefitinib systemic (More...) |
0 Review(s) | Not rated - Be the first |
| lapatinib systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first |
| sorafenib systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first |
| sunitinib systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first |
See also
Medical Conditions associated with tyrosine kinase inhibitors:
- Acute Lymphoblastic Leukemia
- Breast Cancer
- Chronic Eosinophilic Leukemia
- Chronic Myelogenous Leukemia (CML)
- Dermatofibrosarcoma Protuberans
- Gastrointestinal Stromal Tumor
- Hepatocellular Carcinoma
- Hypereosinophilic Syndrome
- Leukemia
- Myelodysplastic Diseases
- Myeloproliferative Disorders
- Non-Small Cell Lung Cancer
- Pancreatic Cancer
- Renal Cell Carcinoma
- Systemic Mastocytosis
- Thyroid Cancer
